HomeNNNN • NASDAQ
add
Anbio Biotechnology
Previous close
$24.06
Day range
$23.05 - $26.00
Year range
$5.18 - $55.65
Market cap
1.13B USD
Avg Volume
61.28K
P/E ratio
416.53
Dividend yield
-
Primary exchange
NASDAQ
Market news
The Wall Street Journal
12 hours ago
The Road to Dow 50000 Was Perilous. What’s Next Could be Rockier.
2.47%
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 2.29M | -21.63% |
Operating expense | 432.72K | 177.16% |
Net income | 1.90M | 5.60% |
Net profit margin | 82.84 | 34.74% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.43M | 30.25% |
Total assets | 27.68M | 46.12% |
Total liabilities | 131.13K | -75.15% |
Total equity | 27.55M | — |
Shares outstanding | 43.89M | — |
Price to book | 38.19 | — |
Return on assets | 15.21% | — |
Return on capital | 15.28% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 1.90M | 5.60% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2021
Website
Employees
27
